Sheppard JD - Search Results

1

Adenovirus Ocular Infections: Prevalence, Pathology, Pitfalls, and Practical Pointers.

Garcia-Zalisnak D, Rapuano C, Sheppard JD, Davis AR. Garcia-Zalisnak D, et al. Among authors: sheppard jd. Eye Contact Lens. 2018 Sep;44 Suppl 1:S1-S7. doi: 10.1097/ICL.0000000000000226. Eye Contact Lens. 2018. PMID: 29664772 Review.

2

Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.

Sheppard JD, Donnenfeld ED, Holland EJ, Slonim CB, Solomon R, Solomon KD, McDonald MB, Perry HD, Lane SS, Pflugfelder SC, Samudre SS. Sheppard JD, et al. Eye Contact Lens. 2014 Sep;40(5):289-96. doi: 10.1097/ICL.0000000000000049. Eye Contact Lens. 2014. PMID: 25083776 Clinical Trial.

3

Herpes Zoster Ophthalmicus Review and Prevention.

Davis AR, Sheppard J. Davis AR, et al. Eye Contact Lens. 2019 Sep;45(5):286-291. doi: 10.1097/ICL.0000000000000591. Eye Contact Lens. 2019. PMID: 30844951 Review.

4

Current and Future Pharmacological Therapies for the Management of Dry Eye.

Gupta PK, Asbell P, Sheppard J. Gupta PK, et al. Eye Contact Lens. 2020 Mar;46 Suppl 2:S64-S69. doi: 10.1097/ICL.0000000000000666. Eye Contact Lens. 2020. PMID: 31625981 Review.

5

Gut Microbiome and Its Influence On Ocular Surface and Ocular Surface Diseases.

Thakur S, Sheppard JD. Thakur S, et al. Among authors: sheppard jd. Eye Contact Lens. 2022 Jul 1;48(7):278-282. doi: 10.1097/ICL.0000000000000905. Epub 2022 May 17. Eye Contact Lens. 2022. PMID: 35580364 Review.

6

Antibiotic resistance in acute postoperative endophthalmitis.

Holland EJ, McDonald MB, Parekh JG, Sheppard JD. Holland EJ, et al. Among authors: sheppard jd. Ophthalmology. 2014 Nov;121(11 Suppl):S1-9; quiz S10-2. doi: 10.1016/j.ophtha.2014.06.049. Ophthalmology. 2014. PMID: 25283879 Review.

7

Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease.

Goldstein MH, Martel JR, Sall K, Goldberg DF, Abrams M, Rubin J, Sheppard J, Tauber J, Korenfeld M, Agahigian J, Durham TA, Furfine E. Goldstein MH, et al. Eye Contact Lens. 2017 Sep;43(5):287-296. doi: 10.1097/ICL.0000000000000276. Eye Contact Lens. 2017. PMID: 27466718 Clinical Trial.

8

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study.

Sheppard J, Kannarr S, Luchs J, Malhotra R, Justice A, Ogundele A, Darby C, Bacharach J. Sheppard J, et al. Eye Contact Lens. 2020 Jan;46 Suppl 1:S14-S19. doi: 10.1097/ICL.0000000000000636. Eye Contact Lens. 2020. PMID: 31361655 Clinical Trial.

9

Emerging therapies for dry eye disease.

Mason L, Jafri S, Dortonne I, Sheppard JD Jr. Mason L, et al. Among authors: sheppard jd jr. Expert Opin Emerg Drugs. 2021 Dec;26(4):401-413. doi: 10.1080/14728214.2021.2011858. Epub 2021 Dec 7. Expert Opin Emerg Drugs. 2021. PMID: 34846978 Review.

10

Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.

Sheppard JD, Scoper SV, Samudre S. Sheppard JD, et al. J Ocul Pharmacol Ther. 2011 Feb;27(1):23-7. doi: 10.1089/jop.2010.0085. Epub 2010 Dec 6. J Ocul Pharmacol Ther. 2011. PMID: 21133792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page